These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30652497)

  • 21. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3.
    Lin Y; Yang Y
    Pathol Res Pract; 2019 Apr; 215(4):683-688. PubMed ID: 30600184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line.
    Luo M; Hu L; Li D; Wang Y; He Y; Zhu L; Ren W
    Mol Immunol; 2017 Oct; 90():1-10. PubMed ID: 28654770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Methoxytryptophan ameliorates endotoxin-induced acute lung injury in vivo and in vitro by inhibiting NLRP3 inflammasome-mediated pyroptosis through the Nrf2/HO-1 signaling pathway.
    Ma Y; Wang Z; Wu X; Ma Z; Shi J; He S; Li S; Li X; Li X; Li Y; Yu J
    Inflamm Res; 2023 Aug; 72(8):1633-1647. PubMed ID: 37458783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artesunate Inhibits Renal Ischemia-Reperfusion-Mediated Remote Lung Inflammation Through Attenuating ROS-Induced Activation of NLRP3 Inflammasome.
    Liu Z; Qu M; Yu L; Song P; Chang Y
    Inflammation; 2018 Aug; 41(4):1546-1556. PubMed ID: 29730819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice.
    Chen J; Wang S; Fu R; Zhou M; Zhang T; Pan W; Yang N; Huang Y
    J Transl Med; 2018 Aug; 16(1):233. PubMed ID: 30126430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury.
    Yang Y; Yang F; Yu X; Wang B; Yang Y; Zhou X; Cheng R; Xia S; Zhou X
    Biomed Pharmacother; 2019 Apr; 112():108664. PubMed ID: 30784935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aloperine alleviates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome activation.
    Zeng J; Liu J; Huang JH; Fu SP; Wang XY; Xi C; Cui YR; Qu F
    Int Immunopharmacol; 2023 Jul; 120():110142. PubMed ID: 37210910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-linolenic acid pretreatment alleviates NETs-induced alveolar macrophage pyroptosis by inhibiting pyrin inflammasome activation in a mouse model of sepsis-induced ALI/ARDS.
    Liu C; Zhou Y; Tu Q; Yao L; Li J; Yang Z
    Front Immunol; 2023; 14():1146612. PubMed ID: 37051243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
    Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
    Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury.
    Jones HD; Crother TR; Gonzalez-Villalobos RA; Jupelli M; Chen S; Dagvadorj J; Arditi M; Shimada K
    Am J Respir Cell Mol Biol; 2014 Feb; 50(2):270-80. PubMed ID: 24007300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HEMIN ATTENUATED LPS-INDUCED ACUTE LUNG INJURY IN MICE VIA PROTECTING PULMONARY EPITHELIAL BARRIER AND REGULATING HO-1/NLRP3-MEDIATED PYROPTOSIS.
    Cheng X; Yin M; Sun X; Zhang Z; Yao X; Liu H; Xia H
    Shock; 2023 May; 59(5):744-753. PubMed ID: 36821407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of STAT6 enhances murine acute lung injury through NLRP3/p38 MAPK signaling pathway in macrophages.
    Hu L; Shao C; Pan L; Jiang Z
    BMC Immunol; 2022 May; 23(1):25. PubMed ID: 35606692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ejiao ameliorates lipopolysaccharide-induced pulmonary inflammation via inhibition of NFκB regulating NLRP3 inflammasome and mitochondrial ROS.
    Yue Q; Zhang W; Lin S; Zheng T; Hou Y; Zhang Y; Li Z; Wang K; Yue L; Abay B; Li M; Fan L
    Biomed Pharmacother; 2022 Aug; 152():113275. PubMed ID: 35714510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the NLRP3 inflammasome and macrophage pyroptosis by the p38 MAPK signaling pathway in a mouse model of acute lung injury.
    Li D; Ren W; Jiang Z; Zhu L
    Mol Med Rep; 2018 Nov; 18(5):4399-4409. PubMed ID: 30152849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
    Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
    Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model.
    Zhong WJ; Yang HH; Guan XX; Xiong JB; Sun CC; Zhang CY; Luo XQ; Zhang YF; Zhang J; Duan JX; Zhou Y; Guan CX
    J Cell Physiol; 2019 Apr; 234(4):4641-4654. PubMed ID: 30256406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus-delivered angiopoietin-1 ameliorates phosgene-induced acute lung injury via inhibition of NLRP3 inflammasome activation.
    He DK; Chen JF; Shao YR; Zhou FQ; Shen J
    Inhal Toxicol; 2018; 30(4-5):187-194. PubMed ID: 30257148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wolf-Hirschhorn syndrome candidate 1 facilitates alveolar macrophage pyroptosis in sepsis-induced acute lung injury through NEK7-mediated NLRP3 inflammasome activation.
    Liu C; Cai B; Li D; Yao Y
    Innate Immun; 2021 Aug; 27(6):437-447. PubMed ID: 34428935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buformin alleviates sepsis-induced acute lung injury via inhibiting NLRP3-mediated pyroptosis through an AMPK-dependent pathway.
    Liu B; Wang Z; He R; Xiong R; Li G; Zhang L; Fu T; Li C; Li N; Geng Q
    Clin Sci (Lond); 2022 Feb; 136(4):273-289. PubMed ID: 35132999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AMPK as a potential pharmacological target for alleviating LPS-induced acute lung injury partly via NLRC4 inflammasome pathway inhibition.
    He Y; Xu K; Wang Y; Chao X; Xu B; Wu J; Shen J; Ren W; Hu Y
    Exp Gerontol; 2019 Oct; 125():110661. PubMed ID: 31319131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.